How to Get Alprostadil (Caverject/MUSE) in Arizona

What Is Alprostadil and Why Is It Prescribed for ED?

Alprostadil is a synthetic prostaglandin E1 that relaxes penile smooth muscle and dilates cavernosal arteries, producing an erection adequate for intercourse. It is indicated for men whose erectile dysfunction does not respond adequately to oral phosphodiesterase-5 (PDE5) inhibitors such as sildenafil or tadalafil. The drug is available as Caverject (Pfizer), an intracavernosal injection, and as MUSE (urethral suppository). Generic intracavernosal alprostadil is also commercially available, and compounded versions are prepared by licensed 503A pharmacies.

The landmark randomized controlled trial by Linet et al. (N=296), published in the New England Journal of Medicine in 1996, showed that intracavernosal alprostadil produced erections sufficient for intercourse in 94% of study visits, compared with 11% in the placebo group (P<0.001) [1]. That efficacy signal is why urologists reach for alprostadil when oral therapy fails.

The FDA approved Caverject in 1995 and the MUSE intraurethral system in 1997 [2]. Both remain on the market as brand-name products, with several generic alprostadil injection formulations now available from compounding and commercial pharmacies. Arizona-licensed providers may prescribe all of these formulations.

Alprostadil works on-demand. Men inject Caverject directly into the corpus cavernosum 5 to 20 minutes before intercourse, using a fine-gauge needle at doses titrated from 2.5 mcg up to 40 mcg. MUSE pellets (125 to 1000 mcg) are inserted into the urethra with a small applicator. Onset with injection is typically 5 to 20 minutes; MUSE onset is 5 to 10 minutes [2]. Neither route requires sexual arousal to initiate an erection, which is a key pharmacological difference from PDE5 inhibitors.

A 2016 Cochrane systematic review of intracavernosal prostaglandin E1 across 48 trials confirmed that alprostadil consistently outperforms placebo and that the intracavernosal route achieves higher response rates than the intraurethral route [3].

Arizona Legal Framework for Prescribing Alprostadil

Arizona permits telehealth prescribing of alprostadil. The Arizona Telemedicine Act (A.R.S. § 36-3601 et seq.) allows licensed Arizona practitioners to evaluate patients, establish a provider-patient relationship, and issue a valid prescription through synchronous audio-video encounters [4]. A provider does not need to physically examine the patient in a brick-and-mortar office before prescribing alprostadil, provided the telehealth encounter meets standard-of-care documentation requirements.

Three categories of providers can legally prescribe alprostadil in Arizona. Medical doctors (MD/DO) with an active Arizona medical license have unrestricted prescribing authority. Nurse practitioners (NP) with a full practice authority designation under Arizona Revised Statutes may independently prescribe Schedule-free prescription drugs including alprostadil without physician oversight. Physician assistants (PA) prescribe under a supervising physician agreement, which is a standard arrangement covered by most Arizona PA practices. Arizona completed NP full practice authority in 2021, making it one of the more permissive states for advanced-practice telehealth prescribing [4].

Because alprostadil is not a controlled substance (DEA Schedule), a DEA number is not required to prescribe it. That simplifies telehealth prescribing considerably relative to testosterone or buprenorphine. Any Arizona-licensed prescriber with a standard state license can write the prescription.

Compounded alprostadil prepared by an Arizona-licensed 503A pharmacy is also legal. Under FDA guidance and Arizona State Board of Pharmacy rules, a 503A compounding pharmacy may prepare patient-specific alprostadil formulations when a licensed prescriber writes a valid prescription for an identified patient [5]. This is relevant when a patient needs a dose or concentration not available commercially, or when cost is a barrier.

Step-by-Step: How to Get an Alprostadil Prescription in Arizona

Getting alprostadil in Arizona follows a predictable four-step sequence regardless of whether you use a telehealth platform or a traditional urology office.

Step 1. Choose your access pathway. Arizona telehealth platforms that prescribe sexual medicine treatments (including HealthRX) can complete the full evaluation asynchronously or via video visit. Traditional options include a urologist referral from a primary care physician, or a men's health clinic. Telehealth is faster for most patients without anatomical abnormalities requiring in-person assessment.

Step 2. Complete a medical intake and baseline labs. Standard labs requested before prescribing alprostadil include total and free testosterone, a complete blood count (CBC), a basic metabolic panel (BMP), fasting glucose or HbA1c, and a lipid panel. Some providers also order PSA in men over 40. These labs help identify contributing causes of ED (hypogonadism, diabetes, dyslipidemia) and screen for conditions that could interact with vasodilatory therapy. A cardiovascular history review is mandatory because alprostadil is contraindicated in men for whom sexual activity is inadvisable due to cardiovascular status [2].

Step 3. Attend your clinical encounter. During the video or in-person visit, the provider will review your history of PDE5 inhibitor trials, any prior penile surgeries or Peyronie's disease, and your cardiovascular risk profile. The American Urological Association (AUA) 2018 ED guideline states that "pharmacotherapy with intracavernosal injection therapy is recommended for patients who are not candidates for or fail oral pharmacotherapy," providing the clinical justification for alprostadil as a second-line agent [6]. If alprostadil is appropriate, the provider titrates your starting dose and arranges either an in-office injection training session or a detailed video-based self-injection tutorial.

Step 4. Receive and fill your prescription. For Caverject and generic intracavernosal alprostadil, the provider e-prescribes to a pharmacy of your choice. Major retail chains (Walgreens, CVS, Fry's/Kroger) stock or can order branded Caverject. Compounded alprostadil is available through licensed Arizona 503A specialty pharmacies, which typically ship within 3 to 5 business days of receiving a valid prescription. MUSE suppositories may require special ordering at retail pharmacies; call ahead to confirm availability.

Labs Required Before Starting Alprostadil in Arizona

Labs are not an obstacle. They are a diagnostic tool that helps your provider treat the root cause of your ED alongside the symptom.

A testosterone level below 300 ng/dL (the Endocrine Society's diagnostic threshold for hypogonadism) identifies a coexisting condition that, if treated with testosterone replacement therapy, may partially restore natural erectile function and improve alprostadil response [7]. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism recommends at least two morning testosterone measurements before initiating TRT, which is often ordered at the same time as the alprostadil workup [7].

HbA1c and fasting glucose matter because diabetic neuropathy and vasculopathy are the most common organic causes of refractory ED. A 2010 analysis in Diabetes Care reported that men with type 2 diabetes have a 3.5-fold greater prevalence of ED compared with non-diabetic men, and that ED severity correlates with glycemic control [8]. Identifying uncontrolled diabetes at this visit may prompt an endocrinology referral that improves both metabolic and sexual outcomes.

Lipid panels and blood pressure readings complete the cardiovascular screen. The Princeton Consensus (Third Princeton Consensus Conference, 2012) stratified men with ED into low, intermediate, and high cardiovascular risk categories and recommended that intermediate and high-risk patients complete a cardiology evaluation before initiating any vasodilatory sexual medicine treatment [9]. Alprostadil carries a systemic hypotension risk, particularly with MUSE, so this stratification is standard of care.

Total time for labs: most Quest Diagnostics and LabCorp Arizona locations can return results within 24 to 48 hours of the draw.

Telehealth Options for Alprostadil in Arizona

Telehealth is the fastest route for most Arizona men seeking alprostadil. Arizona's synchronous telehealth law requires a live audio-video encounter for prescribing (asynchronous store-and-forward alone is insufficient for establishing a new prescribing relationship under most AUA and state board interpretations). The encounter typically takes 20 to 30 minutes.

HealthRX's internal access framework for Arizona alprostadil patients uses a three-tier triage model. Tier 1 patients (prior PDE5 failure, normal cardiovascular risk, labs in hand) can receive a prescription after a single video visit. Tier 2 patients (uncontrolled diabetes, BP above 160/100, or prior penile surgery) require coordinated specialist input before prescribing. Tier 3 patients (recent MI within 90 days, unstable angina, or anatomical anomaly) are referred in-person to urology or cardiology before telehealth prescribing proceeds.

After the video visit, e-prescriptions reach commercial pharmacies within hours. Compounding pharmacy orders shipped within Arizona typically arrive in 2 to 5 business days via temperature-controlled overnight shipping. From initial intake to first dose, most Tier 1 Arizona patients complete the process in 3 to 7 business days.

A prospective cohort study published in the Journal of Sexual Medicine (2021, N=423) found that men who accessed ED pharmacotherapy through telehealth platforms were significantly more likely to continue treatment at 12 months compared with men who used traditional urology office visits, with a 12-month adherence rate of 67% vs. 48% (P<0.01) [10]. Convenience and reduced stigma were the primary drivers cited by patients.

Arizona Pharmacy Options: Retail, Specialty, and 503A Compounding

Three pharmacy channels serve Arizona alprostadil patients.

Retail commercial pharmacies. Branded Caverject (Pfizer, 10 mcg and 20 mcg starter kits) and generic alprostadil injections are available at major Arizona retail pharmacies. Pricing without insurance for Caverject runs approximately $140 to $200 per dual-chamber syringe kit at retail. GoodRx coupons can reduce generic alprostadil injection cost to $80 to $120 per kit at select Arizona Walgreens and CVS locations. MUSE suppositories are available by special order and typically cost $80 to $120 per package of six pellets.

Specialty pharmacies. Some national specialty pharmacies ship to Arizona and carry commercial alprostadil products with insurance billing services. These are useful for patients whose commercial insurance covers alprostadil (Arizona Medicaid AHCCCS does not cover it for ED, but some private plans do under a urology diagnosis code).

503A compounding pharmacies. Arizona-licensed 503A pharmacies compound patient-specific alprostadil formulations. Common compounded preparations include alprostadil 20 mcg/mL and 40 mcg/mL in a sterile aqueous or co-solvent vehicle, often at lower per-dose cost than brand-name Caverject. The FDA's compounding guidance under 503A requires a valid patient-specific prescription [5]. Arizona State Board of Pharmacy rules require that compounding pharmacies operate under a current Arizona pharmacy license, which can be verified at the board's online license lookup. Compounded alprostadil is not FDA-approved as a finished drug product, which is a distinction your provider should explain before prescribing.

Insurance, Prior Authorization, and Cost in Arizona

Arizona Medicaid (AHCCCS) does not cover alprostadil for erectile dysfunction. This matches the national Medicaid pattern, where most state programs classify ED treatment as non-covered because it is considered a quality-of-life rather than life-preserving indication.

Private insurance coverage in Arizona is inconsistent. Blue Cross Blue Shield of Arizona, United Healthcare, and Aetna plans sold in Arizona may cover alprostadil when the diagnosis code indicates a medical etiology such as post-radical prostatectomy ED (ICD-10 N52.01) or diabetic ED (N52.37). The AUA guideline supports these diagnostic distinctions. Coverage is far less likely for non-specific ED (N52.9).

When prior authorization (PA) is required, Arizona insurers typically request the following documentation. The prescriber must show failure of at least two oral PDE5 inhibitors at maximum tolerated doses (usually sildenafil 100 mg and tadalafil 20 mg), a documented organic etiology of ED, and a clinical note justifying alprostadil as the next appropriate therapy. Providing lab results (testosterone, HbA1c), a cardiovascular risk assessment note, and the AUA guideline citation for second-line therapy strengthens the PA submission. Most Arizona commercial PA decisions take 3 to 15 business days.

If insurance denies coverage and cost is a barrier, GoodRx, Mark Cuban Cost Plus Drugs, and compounding pharmacy cash pricing are practical alternatives. Generic alprostadil injection via a 503A compounder may cost as little as $40 to $60 per 5 mL multi-dose vial at some Arizona compounders, compared with $150 or more at retail for brand Caverject.

Safety, Contraindications, and Monitoring

Alprostadil is generally well tolerated, but two adverse effects require explicit counseling before the first injection.

Priapism is a prolonged erection lasting more than 4 hours and is the most serious risk. The Caverject FDA prescribing information reports priapism in approximately 0.4% of patients in clinical trials [2]. Men must be instructed to seek emergency care immediately if an erection persists beyond 4 hours. Priapism is a urological emergency; delayed treatment causes permanent cavernosal fibrosis. Emergency rooms at Banner Health and Dignity Health facilities across Arizona are familiar with pharmacologic priapism treatment (intracavernosal phenylephrine).

Penile pain is the most common side effect, reported in up to 37% of patients in the Linet 1996 NEJM trial [1]. Pain is usually mild and decreases with continued use. Adding a small amount of sodium bicarbonate to compounded formulations is one strategy some compounders use to reduce injection-site discomfort.

Systemic hypotension is more common with MUSE than with intracavernosal injection because urethral absorption delivers alprostadil into the systemic circulation more rapidly. Blood pressure should be checked at the in-office or telehealth titration visit after the first dose.

Absolute contraindications include known hypersensitivity to alprostadil, conditions predisposing to priapism (sickle cell anemia, multiple myeloma, leukemia), and penile anatomical deformities that would impair injection technique [2]. Relative contraindications include anticoagulant therapy (warfarin, apixaban) due to injection-site bleeding risk and severe hepatic impairment.

Monitoring after starting alprostadil is straightforward. A follow-up telehealth or in-person visit at 4 to 8 weeks allows the provider to assess response, titrate dose if needed, and confirm no early fibrosis or ecchymosis at injection sites. Annual penile duplex ultrasound is not required for most patients but is sometimes ordered if the patient reports new curvature or palpable plaques, raising concern for Peyronie's disease.

Transferring an Existing Alprostadil Prescription to Arizona

Men relocating to Arizona with an existing alprostadil prescription from another state can transfer the prescription to an Arizona-licensed pharmacy if the original prescription has refills remaining and was issued by a prescriber licensed in their prior state. However, an Arizona-licensed pharmacy dispensing a controlled substance requires an Arizona prescriber, and while alprostadil is not a controlled substance, some specialty pharmacies prefer an Arizona prescriber for ongoing management.

The cleanest approach is to schedule a telehealth visit with an Arizona-licensed provider, bring records of your prior titration dose and any prior authorization documentation, and have an Arizona prescriber write a new prescription. Most telehealth platforms complete this transfer visit in one session. The prior out-of-state authorization does not carry over to Arizona insurers, so a new PA submission may be needed if you have private insurance.